Cardiol Therapeutics Inc
TSX:CRDL

Watchlist Manager
Cardiol Therapeutics Inc Logo
Cardiol Therapeutics Inc
TSX:CRDL
Watchlist
Price: 1.81 CAD -3.21%
Market Cap: 147.7m CAD
Have any thoughts about
Cardiol Therapeutics Inc?
Write Note

Intrinsic Value

CRDL's intrinsic value estimate is unreliable because it is based only on its DCF value and doesn't use a relative valuation using multiples.

The intrinsic value of one CRDL stock under the Base Case scenario is 0.73 CAD. Compared to the current market price of 1.81 CAD, Cardiol Therapeutics Inc is Overvalued by 60%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CRDL Intrinsic Value
0.73 CAD
Overvaluation 60%
Intrinsic Value
Price
Base Case Scenario

Valuation History
Cardiol Therapeutics Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
CRDL
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for CRDL cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about CRDL?
Bearish
Neutral
Bullish

Fundamental Analysis

1.81 CAD
-3.21%
-3.21%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Cardiol Therapeutics Inc
CA
Pharmaceuticals
Market Cap
147.7m CAD
IPO
Dec 20, 2018
Employees
11
Canada
Market Cap
147.7m CAD
Industry
Pharmaceuticals
IPO
Dec 20, 2018
Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Cardiol Therapeutics Inc

Provide an overview of the primary business activities
of Cardiol Therapeutics Inc.

What unique competitive advantages
does Cardiol Therapeutics Inc hold over its rivals?

What risks and challenges
does Cardiol Therapeutics Inc face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Cardiol Therapeutics Inc.

Provide P/S
for Cardiol Therapeutics Inc.

Provide P/E
for Cardiol Therapeutics Inc.

Provide P/OCF
for Cardiol Therapeutics Inc.

Provide P/FCFE
for Cardiol Therapeutics Inc.

Provide P/B
for Cardiol Therapeutics Inc.

Provide EV/S
for Cardiol Therapeutics Inc.

Provide EV/GP
for Cardiol Therapeutics Inc.

Provide EV/EBITDA
for Cardiol Therapeutics Inc.

Provide EV/EBIT
for Cardiol Therapeutics Inc.

Provide EV/OCF
for Cardiol Therapeutics Inc.

Provide EV/FCFF
for Cardiol Therapeutics Inc.

Provide EV/IC
for Cardiol Therapeutics Inc.

Show me price targets
for Cardiol Therapeutics Inc made by professional analysts.

What are the Revenue projections
for Cardiol Therapeutics Inc?

How accurate were the past Revenue estimates
for Cardiol Therapeutics Inc?

What are the Net Income projections
for Cardiol Therapeutics Inc?

How accurate were the past Net Income estimates
for Cardiol Therapeutics Inc?

What are the EPS projections
for Cardiol Therapeutics Inc?

How accurate were the past EPS estimates
for Cardiol Therapeutics Inc?

What are the EBIT projections
for Cardiol Therapeutics Inc?

How accurate were the past EBIT estimates
for Cardiol Therapeutics Inc?

Compare the revenue forecasts
for Cardiol Therapeutics Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Cardiol Therapeutics Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Cardiol Therapeutics Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Cardiol Therapeutics Inc compared to its peers.

Compare the P/E ratios
of Cardiol Therapeutics Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Cardiol Therapeutics Inc with its peers.

Analyze the financial leverage
of Cardiol Therapeutics Inc compared to its main competitors.

Show all profitability ratios
for Cardiol Therapeutics Inc.

Provide ROE
for Cardiol Therapeutics Inc.

Provide ROA
for Cardiol Therapeutics Inc.

Provide ROIC
for Cardiol Therapeutics Inc.

Provide ROCE
for Cardiol Therapeutics Inc.

Provide Gross Margin
for Cardiol Therapeutics Inc.

Provide Operating Margin
for Cardiol Therapeutics Inc.

Provide Net Margin
for Cardiol Therapeutics Inc.

Provide FCF Margin
for Cardiol Therapeutics Inc.

Show all solvency ratios
for Cardiol Therapeutics Inc.

Provide D/E Ratio
for Cardiol Therapeutics Inc.

Provide D/A Ratio
for Cardiol Therapeutics Inc.

Provide Interest Coverage Ratio
for Cardiol Therapeutics Inc.

Provide Altman Z-Score Ratio
for Cardiol Therapeutics Inc.

Provide Quick Ratio
for Cardiol Therapeutics Inc.

Provide Current Ratio
for Cardiol Therapeutics Inc.

Provide Cash Ratio
for Cardiol Therapeutics Inc.

What is the historical Revenue growth
over the last 5 years for Cardiol Therapeutics Inc?

What is the historical Net Income growth
over the last 5 years for Cardiol Therapeutics Inc?

What is the current Free Cash Flow
of Cardiol Therapeutics Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Cardiol Therapeutics Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Cardiol Therapeutics Inc

Current Assets 17.3m
Cash & Short-Term Investments 15.9m
Receivables 266.7k
Other Current Assets 1.1m
Non-Current Assets 237.9k
PP&E 237.9k
Current Liabilities 7m
Accounts Payable 6.9m
Other Current Liabilities 35.4k
Non-Current Liabilities 134.2k
Long-Term Debt 134.2k
Efficiency

Earnings Waterfall
Cardiol Therapeutics Inc

Revenue
0 CAD
Operating Expenses
-38.3m CAD
Operating Income
-38.3m CAD
Other Expenses
2.2m CAD
Net Income
-36.1m CAD

Free Cash Flow Analysis
Cardiol Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

CRDL Profitability Score
Profitability Due Diligence

Cardiol Therapeutics Inc's profitability score is 39/100. The higher the profitability score, the more profitable the company is.

39/100
Profitability
Score

Cardiol Therapeutics Inc's profitability score is 39/100. The higher the profitability score, the more profitable the company is.

CRDL Solvency Score
Solvency Due Diligence

Cardiol Therapeutics Inc's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
Short-Term Solvency
Long-Term Solvency
60/100
Solvency
Score

Cardiol Therapeutics Inc's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CRDL Price Targets Summary
Cardiol Therapeutics Inc

Wall Street analysts forecast CRDL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CRDL is 9.95 CAD with a low forecast of 8.59 CAD and a high forecast of 11.55 CAD.

Lowest
Price Target
8.59 CAD
374% Upside
Average
Price Target
9.95 CAD
449% Upside
Highest
Price Target
11.55 CAD
538% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for CRDL?

Click here to dive deeper.

Dividends

Cardiol Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for CRDL is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

See Also

Discover More
What is the Intrinsic Value of one CRDL stock?

The intrinsic value of one CRDL stock under the Base Case scenario is 0.73 CAD.

Is CRDL stock undervalued or overvalued?

Compared to the current market price of 1.81 CAD, Cardiol Therapeutics Inc is Overvalued by 60%.

Back to Top